Jaguar Health announced that Magdalena Biosciences, the joint venture recently formed by Jaguar and Filament Health, to develop novel, natural prescription medicines derived from plants for mental health indications such as depression, anxiety, attention-deficit/hyperactivity disorder and other possible neuropsychiatric conditions initially in adults, has received the second tranche of funding from One Small Planet. As announced, Boulder, Colorado-based One Small Planet, founded by Will Peterffy, committed to initial funding of $1,000,000 for Magdalena, with the funds payable in quarterly installments in 2023 based on the achievement of defined milestones by Magdalena.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JAGX:
- ITOT ETF: An Ideal Building Block for New Investors
- Meet Jaguar Health: Fly exclusive interview with CEO Lisa Conte
- Phase 3 Crofelamer expansion trial data expected soon, Jaguar CEO says
- Jaguar CEO says TikTok, Instagram campaign important to raise awareness
- Jaguar Health lead product can have big impact, CEO tells The Fly